https://www.selleckchem.com/products/sc79.html
Apart from risk factor modification, calcium channel blockers are currently the first line treatment, with nitrates playing an important adjunct role. High-risk patients with life-threatening complications should be considered for implantable cardioverter defibrillator (ICD), although timing criteria for escalated therapy require further investigation. The role of pharmaceuticals targeting oxidative stress remains incompletely understood.Coronary artery aneurysm (CAA) is a clinical entity defined by a focal enlargement of the coronary arte
Aimer
Commentaire
Partagez
